Evidence map›Paper›PMID 18771643›Full record

ArticleSexual health2008

Attitudes of men in an Australian male tolerance study towards microbicide use.

Wendy R Holmes, Lisa Maher, Susan L Rosenthal

Open access · greenAbstract readClinical Trial, Phase I
In one paragraph

Article in Sexual health, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.6field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 17 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Review
  4. Review
  5. Review
  6. Review
  7. Article
  8. Perceptions of reimbursement for clinical trial participation.Journal of empirical research on human research ethics : JERHRE · 2011
    Article
  9. Relationship context associated with microbicide-like product use.Journal of pediatric and adolescent gynecology · 2009
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Wendy R HolmesCentre for International Health, Macfarlane Burnet Institute for Medical Research and Public Health, 23?87 Commercial Road, Melbourne, Vic. 3004, Australia. holmes@burnet.edu.au
Lisa Maher
Susan L Rosenthal
Accessible Designs (United States) · US

Funding

MICROBICIDES: DEVELOPMENTAL CONTEXT OF ACCEPTABILITYR01HD040151 · NICHD · UNIVERSITY OF TEXAS MEDICAL BR GALVESTON · PI ROSENTHAL, SUSAN L · 2000 to 2004
$2.0M
NICHD NIH HHS R01 HD040151NICHD NIH HHS R01 HD40151-01PHS HHS HHSN266200500042C
6 · The paper itself

Abstract

backgroundVaginal microbicides are in development to provide new options for the prevention of sexually transmissible infections. Although promoted as a female-initiated product, men may influence the decision to use a microbicide and the way that it is used, so it is important to explore their views.

methodsMen (n = 36) enrolled in a 7-day, phase 1 clinical safety trial of SPL7013 Gel were interviewed pre- and post-use of the gel. The trial did not include use of the gel during sex. Interviews were digitally-recorded and transcribed verbatim, and analysed using a framework approach.

resultsThe men (mean age 37 years) were interested in the idea of vaginal microbicides, had little knowledge about them, and varied beliefs about how they work. They tended to assess microbicide use in relation to condoms and lubricants. Many would want a microbicide to be as effective as condoms. Participants did not anticipate difficulties discussing use with their partners. Many thought that a microbicide would be less intrusive than condoms; some anticipated that the lubricating properties might enhance sexual pleasure. Some anticipated using a microbicide with a condom or with a lubricant, and a few raised questions about the timing of use and use during different types of sexual activity.

conclusionsNo major barriers to microbicide use were found in this sample of Australian men, who anticipated being willing to use them if they are shown to be safe and effective. Our findings should help to inform the design of further studies as well as future information materials and anticipatory guidance.

Indexed as

Health Knowledge, Attitudes, PracticeAdministration, IntravaginalAdultAgedAnti-Infective AgentsAustraliaDendrimersHumansMaleMiddle AgedPatient Acceptance of Health CarePolylysineSafe SexSexually Transmitted Diseases, BacterialSpermatocidal AgentsSurveys and QuestionnairesAnti-Infective AgentsastodrimerDendrimersPolylysineSpermatocidal Agents

Identifiers

PMID18771643
PMCPMC3777800
OpenAlexW2079305382

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.